机译:患有vivaxmalaria患者Tafeoine疗效的药物发生评估
PAREXEL Int Genom Med Durham NC 27713 USA;
GlaxoSmithKline Stockley Pk West Uxbridge Middx England;
GlaxoSmithKline Collegeville PA USA;
Res Inst Trop Med Manila Philippines;
Oxford Univ Clin Res Unit Ho Chi Minh City Vietnam;
Mahidol Univ Bangkok Thailand;
Fundacao Med Trop Amazonas Manaus Amazonas Brazil;
Univ Peruana Cayetano Heredia Lima Peru;
Armed Forces Res Inst Med Sci Bangkok Thailand;
Univ Gondar Gondar Ethiopia;
Umphang Hosp Tak Thailand;
Ctr Pesquisa Med Trop Rondonia Porto Velho Brazil;
Armed Forces Res Inst Med Sci Bangkok Thailand;
Univ Antioquia PECET Medellin Colombia;
Jimma Univ Jimma Ethiopia;
Ctr Invest Clin Cali Colombia;
Med Malaria Venture Geneva Switzerland;
GlaxoSmithKline Stockley Pk West Uxbridge Middx England;
efficacy; pharmacogenetics; Plasmodium vivaxmalaria; tafenoquine;
机译:患有vivaxmalaria患者Tafeoine疗效的药物发生评估
机译:评估葡萄糖-6-磷酸脱氢酶(G6PD)酶活性的基于百分比的报告:评估患者资格对疟疾预防和酪蛋白的治疗
机译:对疟原虫疟原虫疟疾疟原虫治疗中随机临床试验中接受TaFenoIquine或氯喹/初级患者的比较眼科评估
机译:从神经咽喉康复观点出发的精神分裂症患者和颅骨患者的疗效
机译:评估影响药学学生患者咨询自我效能的反馈因素。
机译:谷胱甘肽S-转移酶基因对非小细胞肺癌患者铂类化疗疗效的药物遗传学预测评估
机译:疟原虫疟疾疟疾患者TafenoIquine疗效的药物发生评估